Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.


CHMP backs AZ's 'superbug' antibiotic product

CHMP backs AZ's 'superbug' antibiotic product In the US, Actavis (now operating as Allergan) has been granted FDA approval for another combination of ceftazidime and avibactam, which is sold as Avycaz. ... Actavis gained rights to the combination after buying Forest Labs, which originally developed

US tax changes claim Pfizer scalp as Allergan deal abandoned

US tax changes claim Pfizer scalp as Allergan deal abandoned So for Allergan - formerly known as Actavis, its acquisitions of Warner Chilcott in 2013, Forest Laboratories in 2014 and Allergan in 2015 that turned it into a $109bn company would be

Size matters?

Size matters? It merged with Actavis in March in a $70.5bn deal and then reached an agreement to sell its generics business to Teva for $40.5bn The Teva deal, due to

UK court backs Actavis in dispute over Lilly's Alimta

UK court backs Actavis in dispute over Lilly's Alimta drug's side effects - is not infringed by a generic version of the drug sold by Allergan's Actavis unit. ... patent would not be infringed by yet another salt - Actavis' pemetrexed dipotassium - after the December 2015 compound patent expiration.

UK government fines GSK over 'pay-for-delay' deals

UK government fines GSK over 'pay-for-delay' deals Merck KGaA and Actavis also fined for their involvement. The UK's Competition &Markets Authority has fined GlaxoSmithKline (GSK) and several other companies for delaying the availability of generic versions of ... Actavis which have both been fined for

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...